As diabetes care continues to be a crucial focus, new treatments are emerging . Retatrutide, Tirzepatide, and Semaglutide represent a noteworthy advancement in GLP-1 receptor agonist medications. While all aim https://nimmansocial.com/story12309897/the-new-drug-vs-tirzepatid-vs-this-injection-a-direct-comparison